Transcatheter aortic valve replacement for pure aortic valve regurgitation: “on-label” versus “off-label” use of TAVR devices
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-019-01422-0
Abstract: IntroductionTranscatheter aortic valve replacement (TAVR) has become the mainstay of treatment for aortic stenosis in patients with high surgical risk. Pure aortic regurgitation (PAR) is considered a relative contraindication for TAVR; however, TAVR is increasingly… read more here.
Keywords: label; tavr devices; aortic valve; par ... See more keywords